—
C+
C+ The full Closelook — membership. Open the C+ overview

MiniMed Group, Inc. Common Stock (MMED) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — MiniMed Group, Inc. Common Stock

MMED in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
MiniMed Group builds devices for diabetes care, including insulin pumps, pens and continuous glucose monitors, plus software that ties them together. Its automated insulin delivery systems handle glucose sensing and dosing, while its multiple daily injection line, including InPen and Simplera Sync, supports manual insulin use. Its CareLink platform gives people with diabetes, carers and clinicians a shared view of device data. The company was founded in 1983, is based in Northridge, California, and currently operates as a Medtronic subsidiary.
Where it sits in the stack
MiniMed sits outside the AI build-out stack our indices track; it belongs to Closelook's Healthcare sleeve, within medical instruments and supplies, apart from the compute chain we follow elsewhere.
Who it is priced against
Closelook has not yet fixed a peer group for MiniMed; the market most often names Insulet and Tandem Diabetes Care as comparable insulin-delivery makers, alongside its parent, Medtronic.
Why Closelook tracks it
MiniMed holds no seat in our index, carries no Closelook score yet, and the diary has not quoted it directly; coverage so far sits at the sector level only.
What the diary watches
The diary watches whether MiniMed's planned separation from Medtronic proceeds and whether its device platform builds a usage record independent of its parent's reporting.

MiniMed Group, Inc. Common Stock (MMED) trades on US exchanges, classified under Healthcare.

The Closelook company score reads 46/100 composite (momentum 84, quality 20, valuation 25) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for MMED, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 7 analyst actions on the wire · latest: price target by Deutsche Bank, 2026-09-02

The Street on this name

Analyst actions and the latest print for MMED from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Deutsche Bank — target 25 from 20 Target raised to $25 from $20 (+5.5% to spot) 2026-09-02
  • Price target Evercore ISI — target 27 from 20 Target raised to $27 from $20 (+12% to spot) 2026-09-02
  • Price target UBS — target 28 from 25 Target raised to $28 from $25 (+24.9% to spot) 2026-09-02

7 actions on the analyst wire since 2026-08-13: 7 target changes. Analyst wire → · Earnings wire →

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

Names in the same industry from the Closelook universe; scored names rank on their Closelook score, the rest on trend state.

Compared against MMED on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return no distribution in twelve months

Dividends and capital return

What MMED pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Share count −8.6% in FY2026 46 m USD of stock-based compensation in the year

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sector × region Health care in US: +1.8% week · −4.1% month · +13.2% quarter · +8.1% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-20
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is MiniMed Group, Inc. Common Stock (MMED)?

MiniMed Group, Inc. Common Stock trades as MMED on the US exchange (US) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-19.

Is MMED in a Closelook index?

Not currently — MiniMed Group, Inc. Common Stock is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

What is MiniMed Group, Inc. Common Stock's Closelook composite score?

46 out of 100, with momentum 84, quality 20 and valuation 25 sub-scores, as of 2026-09-19. Scores are Closelook's own research readings, not ratings or investment advice.

What does MiniMed Group, Inc. Common Stock do?

MiniMed Group builds devices for diabetes care, including insulin pumps, pens and continuous glucose monitors, plus software that ties them together. Its automated insulin delivery systems handle glucose sensing and dosing, while its multiple daily injection line, including InPen and Simplera Sync, supports manual insulin use. Its CareLink platform gives people with diabetes, carers and clinicians a shared view of device data. Closelook has not yet fixed a peer group for MiniMed; the market most often names Insulet and Tandem Diabetes Care as comparable insulin-delivery makers, alongside its parent, Medtronic.

Where does MiniMed Group, Inc. Common Stock sit in the AI build-out?

MiniMed sits outside the AI build-out stack our indices track; it belongs to Closelook's Healthcare sleeve, within medical instruments and supplies, apart from the compute chain we follow elsewhere. MiniMed holds no seat in our index, carries no Closelook score yet, and the diary has not quoted it directly; coverage so far sits at the sector level only.

Does MiniMed Group, Inc. Common Stock pay a dividend?

No cash distribution shows in MiniMed Group, Inc. Common Stock’s price series over the last three years. The share count fell 8.6% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on MiniMed Group, Inc. Common Stock recently?

The most recent analyst action on MiniMed Group, Inc. Common Stock on the Closelook wire is a price target by Deutsche Bank on 2026-09-02 (target 25 from 20). 7 actions on the analyst wire since 2026-08-13: 7 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for MMED, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.